trial · primary record
levodopa-carbidopa
Parkinson Disease
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2024-08-20 |
| Primary endpoint | • The primary endpoint is the change in The Unified Parkinson's Disease Rating Scale (UPDRS) |
| Registry ID | NCT05781711 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:44:06.140Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05781711
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.